Gynecomastia differential diagnosis: Difference between revisions

	Gynecomastia Microchapters
Home
Patient Information
Overview
Historical Perspective
Classification
Pathophysiology
Causes
Differentiating Gynecomastia from other Diseases
Epidemiology and Demographics
Risk Factors
Screening
Natural History, Complications and Prognosis
Diagnosis
Diagnostic study of choice
History and Symptoms
Physical Examination
Laboratory Findings
Electrocardiogram
Chest X Ray
CT
MRI
Ultrasound
Other Imaging Findings
Other Diagnostic Studies
Treatment
Medical Therapy
Surgery
Primary Prevention
Secondary Prevention
Cost-Effectiveness of Therapy
Future or Investigational Therapies
Case Studies
Case #1
Gynecomastia differential diagnosis On the Web
Most recent articles
Most cited articles
Review articles
CME Programs
Powerpoint slides
Images
American Roentgen Ray Society Images of Gynecomastia differential diagnosis All Images X-rays Echo & Ultrasound CT Images MRI
Ongoing Trials at Clinical Trials.gov
US National Guidelines Clearinghouse
NICE Guidance
FDA on Gynecomastia differential diagnosis
CDC on Gynecomastia differential diagnosis
Gynecomastia differential diagnosis in the news
Blogs on Gynecomastia differential diagnosis
Directions to Hospitals Treating Gynecomastia
Risk calculators and risk factors for Gynecomastia differential diagnosis

← Older edit Newer edit →

VisualWikitext

Revision as of 16:36, 15 November 2017

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Husnain Shaukat, M.D [2]

Overview

Gynecomastia must be differentiated from other diseases that cause breast enlargement in men. These diseases include pseudo gynecomastia, breast cancer, breast abscess, and lipoma.

Differentiating Gynecomastia from other Diseases

Gynecomastia can be differentiated from other pathologies by detailed history taking and physical examination.^[1]^[2]^[3]

Diseases	Laboratory Findings			Physical Examination					History and Symptoms
Diseases	Estrogen-to-androgen ratio	Cholesterol levels	WBC count	Tenderness	Enlargement	Nipple discharge	Lymphadenopathy	Other physical exam findings	Age of onset	Medication intake
Gynecomastia	↑	N/A	-	+/-	+	+/-	N/A	Round discrete mass felt under areola and usually bilateral	Physiological gynecomastia is seen in newborns, adolescents and elderly	Pharmacological gynecomastia has hx of medication intake.
Pseudo gynecomastia	Normal	N/A	N/A	+/-	+	+/-	N/A	Increased adipose rather than glandular tissue on examination
Breast Cancer	N/A	N/A	N/A	+/-; mostly painless	+	+	+	Usually painless mass	Middle age to elderly
Lipoma	N/A	↑	N/A	+/-	+	+/-	N/A	Soft and mobile	Middle age to elderly
Sebaceous cyst	N/A	N/A	N/A	+/-	+	+/-	+/-	Asymmetric enlargement and swelling feels closer to the skin
Mastitis	N/A	N/A	↑	Tender	+/-	+/-	+/-	Systemic clinical features of infection	Women of childbearing age

References

↑ Dickson G (2012). "Gynecomastia". Am Fam Physician. 85 (7): 716–22. PMID 22534349.
↑ Croes K, Baeyens W, Bruckers L, Den Hond E, Koppen G, Nelen V; et al. (2009). "Hormone levels and sexual development in Flemish adolescents residing in areas differing in pollution pressure". Int J Hyg Environ Health. 212 (6): 612–25. doi:10.1016/j.ijheh.2009.05.002. PMID 19546029.
↑ Laituri CA, Garey CL, Ostlie DJ, St Peter SD, Gittes GK, Snyder CL (2010). "Treatment of adolescent gynecomastia". J Pediatr Surg. 45 (3): 650–4. doi:10.1016/j.jpedsurg.2009.11.016. PMID 20223338.

[pmid22534349-1] Dickson G (2012). "Gynecomastia". Am Fam Physician. 85 (7): 716–22. PMID 22534349.

[pmid19546029-2] Croes K, Baeyens W, Bruckers L, Den Hond E, Koppen G, Nelen V; et al. (2009). "Hormone levels and sexual development in Flemish adolescents residing in areas differing in pollution pressure". Int J Hyg Environ Health. 212 (6): 612–25. doi:10.1016/j.ijheh.2009.05.002. PMID 19546029.

[pmid20223338-3] Laituri CA, Garey CL, Ostlie DJ, St Peter SD, Gittes GK, Snyder CL (2010). "Treatment of adolescent gynecomastia". J Pediatr Surg. 45 (3): 650–4. doi:10.1016/j.jpedsurg.2009.11.016. PMID 20223338.

[1]

[2]

[3]

@@ Line 27: / Line 27: @@
 !Medication intake
 |-
-| style="background: #DCDCDC; padding: 5px; text-align: center;" |Gynecomastia
+| style="background: #DCDCDC; padding: 5px; text-align: center;" |[[Gynecomastia]]
 | style="background: #F5F5F5; padding: 5px;" |'''↑'''
 | style="background: #F5F5F5; padding: 5px;" |N/A
-| style="background: #F5F5F5; padding: 5px;" |-
+| style="background: #F5F5F5; padding: 5px;" | -
 | style="background: #F5F5F5; padding: 5px;" | +/-
 | style="background: #F5F5F5; padding: 5px;" | +
-| style="background: #F5F5F5; padding: 5px;" |+/-
+| style="background: #F5F5F5; padding: 5px;" | +/-
 | style="background: #F5F5F5; padding: 5px;" |N/A
 | style="background: #F5F5F5; padding: 5px;" |
@@ Line 48: / Line 48: @@
 | style="background: #F5F5F5; padding: 5px;" | +/-
 | style="background: #F5F5F5; padding: 5px;" | +
-| style="background: #F5F5F5; padding: 5px;" |+/-
+| style="background: #F5F5F5; padding: 5px;" | +/-
 | style="background: #F5F5F5; padding: 5px;" |N/A
 | style="background: #F5F5F5; padding: 5px;" |
@@ Line 55: / Line 55: @@
 | style="background: #F5F5F5; padding: 5px;" |
 |-
-| style="background: #DCDCDC; padding: 5px; text-align: center;" |Breast Cancer
+| style="background: #DCDCDC; padding: 5px; text-align: center;" |[[Breast cancer|Breast Cancer]]
 | style="background: #F5F5F5; padding: 5px;" |N/A
 | style="background: #F5F5F5; padding: 5px;" |N/A
@@ Line 69: / Line 69: @@
 | style="background: #F5F5F5; padding: 5px;" |
 |-
-| style="background: #DCDCDC; padding: 5px; text-align: center;" |Lipoma
+| style="background: #DCDCDC; padding: 5px; text-align: center;" |[[Lipoma]]
 | style="background: #F5F5F5; padding: 5px;" |N/A
 | style="background: #F5F5F5; padding: 5px;" |'''↑'''
@@ Line 75: / Line 75: @@
 | style="background: #F5F5F5; padding: 5px;" | +/-
 | style="background: #F5F5F5; padding: 5px;" | +
-| style="background: #F5F5F5; padding: 5px;" |+/-
+| style="background: #F5F5F5; padding: 5px;" | +/-
 | style="background: #F5F5F5; padding: 5px;" |N/A
 | style="background: #F5F5F5; padding: 5px;" |
@@ Line 83: / Line 83: @@
 | style="background: #F5F5F5; padding: 5px;" |
 |-
-| style="background: #DCDCDC; padding: 5px; text-align: center;" |Sebaceous cyst
+| style="background: #DCDCDC; padding: 5px; text-align: center;" |[[Sebaceous cyst]]
 | style="background: #F5F5F5; padding: 5px;" |N/A
 | style="background: #F5F5F5; padding: 5px;" |N/A
 | style="background: #F5F5F5; padding: 5px;" |N/A
-| style="background: #F5F5F5; padding: 5px;" |+/-
+| style="background: #F5F5F5; padding: 5px;" | +/-
 | style="background: #F5F5F5; padding: 5px;" | +
-| style="background: #F5F5F5; padding: 5px;" |+/-
+| style="background: #F5F5F5; padding: 5px;" | +/-
-| style="background: #F5F5F5; padding: 5px;" |+/-
+| style="background: #F5F5F5; padding: 5px;" | +/-
 | style="background: #F5F5F5; padding: 5px;" |
 * Asymmetric enlargement and swelling feels closer to the skin
@@ Line 96: / Line 96: @@
 | style="background: #F5F5F5; padding: 5px;" |
 |-
-| style="background: #DCDCDC; padding: 5px; text-align: center;" |Mastitis
+| style="background: #DCDCDC; padding: 5px; text-align: center;" |[[Mastitis]]
 | style="background: #F5F5F5; padding: 5px;" |N/A
 | style="background: #F5F5F5; padding: 5px;" |N/A

Gynecomastia differential diagnosis: Difference between revisions

Revision as of 16:36, 15 November 2017

Overview

Differentiating Gynecomastia from other Diseases

References

Navigation menu

Search